JP Morgan Chase
TYRA icon

JP Morgan Chase’s Tyra Biosciences TYRA Stock Holding History

JP Morgan Chase’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.31M Sell
66,789
-4,386
-6% -$142K ﹤0.01% 3993
2025
Q4 		$1.87M Sell
71,175
-3,054
-4% -$56.1K ﹤0.01% 4121
2025
Q3 		$1.04M Sell
74,229
-28,688
-28% -$327K ﹤0.01% 4558
2025
Q2 		$985K Buy
102,917
+17,427
+20% +$166K ﹤0.01% 4391
2025
Q1 		$795K Sell
85,490
-5,625
-6% -$72.8K ﹤0.01% 4494
2024
Q4 		$1.27M Sell
91,115
-277,532
-75% -$5.04M ﹤0.01% 4458
2024
Q3 		$8.67M Buy
368,647
+3,896
+1% +$81.8K ﹤0.01% 2731
2024
Q2 		$5.83M Sell
364,751
-15,846
-4% -$273K ﹤0.01% 2919
2024
Q1 		$6.24M Sell
380,597
-21,109
-5% -$346K ﹤0.01% 2901
2023
Q4 		$5.56M Buy
401,706
+4,088
+1% +$52.9K ﹤0.01% 2984
2023
Q3 		$5.48M Sell
397,618
-25,803
-6% -$383K ﹤0.01% 2763
2023
Q2 		$7.21M Buy
423,421
+230,912
+120% +$3.35M ﹤0.01% 2575
2023
Q1 		$3.09M Sell
192,509
-6,698
-3% -$79.7K ﹤0.01% 3193
2022
Q4 		$1.51M Sell
199,207
-20,340
-9% -$144K ﹤0.01% 3772
2022
Q3 		$1.93M Sell
219,547
-4,945
-2% -$45.2K ﹤0.01% 3498
2022
Q2 		$1.6M Sell
224,492
-3,990
-2% -$31.8K ﹤0.01% 3719
2022
Q1 		$2.44M Buy
228,482
+73,903
+48% +$877K ﹤0.01% 3604
2021
Q4 		$2.17M Buy
+154,579
New +$3.07M ﹤0.01% 3797

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

JP Morgan Chase's TYRA Position: Q1 2026 in Review

JP Morgan Chase reduced its Tyra Biosciences (TYRA) stake by 6.2% in Q1 2026, selling an estimated $142K and leaving 66,789 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #3993.

JP Morgan Chase first reported a position in TYRA in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.67M in Q3 2024. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • JP Morgan Chase held 66,789 shares of Tyra Biosciences worth $2.31M as of Q1 2026.
  • JP Morgan Chase sold 4,386 Tyra Biosciences shares in Q1 2026, an estimated $142K.
  • Tyra Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3993 holding.
  • JP Morgan Chase first reported a position in Tyra Biosciences in Q4 2021 and has held it in 18 quarters since.
  • JP Morgan Chase's Tyra Biosciences position peaked at $8.67M in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.